ArticleHuman genomics2026

SLC26A2 as a key regulator and therapeutic target in hepatocellular carcinoma: evidence from pan-cancer and mechanistic studies.

Rui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.